Protein Kinases and Cancer: The Promise of Molecular-Based Therapies
Organizer(s): Judith S. Sebolt-Leopold and Charles L. SawyersDate: February 24 - 29, 2004
Location: Granlibakken Tahoe, Tahoe City, CA, USA
Upon completion of this conference, participants should be able to: - Discuss progress made in the cancer research community showing that kinases are druggable targets. - Recognize key signal transduction pathways amenable to pharmacological intervention by kinase inhibitors. - Discuss the critical importance of translational assays in driving clinical trial design of kinase-targeted therapies. - Discuss the application of technologies, encompassing proteomics, genomics, and structural biology, for facilitating novel drug discovery. - Discuss the challenges facing oncologists in deciphering the complexities of individual tumor signaling. - Integrate multidisciplinary leaders involved in basic research, pharmaceutical discovery, and clinical oncology in order to provide all with a better understanding of the numerous steps involved in going from bench to bedside. - Develop new collaborations among the scientists in attendance as well as new insights leading to novel and effective interventions.
Discounted Abstract Deadline: October 23 2003
Discounted Registration Deadline: December 23 2003
We gratefully acknowledge additional support for this conference from:
Cell Signaling Technology, Inc.